Glenmark Pharmaceuticals Limited: insider trades · India · SEBI (PIT + SAST) SEBI:glenmark-pharmaceuticals-limited IN IN · SEBI (PIT + SAST) Mcap 434.6Bn€
Discover the full directors' dealings record of Glenmark Pharmaceuticals Limited, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €434.6bn. The latest transaction was disclosed on 22 September 2023 — Sale. Among the most active insiders: Glenn Mario Saldanha. Every trade is accessible without an account.
Financial data FY ended March 2025 · cache
Income statement
Revenue 131.46 Bn€
Gross profit 83.88 Bn€ 64% margin
Net income 10.47 Bn€ 8.0% margin
Balance sheet & cash
Market cap 434.58 Bn€
Total debt 24.73 Bn€
Free Cash Flow −15.77 Bn€
Last declaration on 22 September 2023
Declarations 13 total
Executives ● Sale0 SEBI
€9,618 1,000 shares @ €9.6182
Equity Shares
SEBI:7c43f029fcf65d701002d87cbc38f4b76c05691e · 20 Sept 2023
Executives ● Sale0 SEBI
€4,804 500 shares @ €9.6072
Equity Shares
SEBI:e66100d169abd1b49336835c9bcfd5956cdd6833 · 20 Sept 2023
Executives ● Sale0 SEBI
€9,618 1,000 shares @ €9.6182
Equity Shares
SEBI:4735f3b198350556570238ed4d2ffa4d36737a5f · 20 Sept 2023
Executives ● Purchase0 SEBI
€1,463 250 shares @ €5.8529
Equity Shares
SEBI:a283ff59f1d01e5f26fe4c410f3339b8dd4e629e · 23 Nov 2021
Ideal exit: 20 Aug 2022 (T+270) Executives ● Sale0 SEBI
€3,514 559 shares @ €6.2857
Equity Shares
SEBI:ad6a757c300c502fcdefcf162081d13e883d157f · 15 Nov 2021
Executives ● Sale0 SEBI
010,000 shares
Equity Shares
SEBI:a1e94610183e8e27382d484204aff805092b4751 · 27 Sept 2021
Executives ● Purchase0 SEBI
020,000 shares
Equity Shares
SEBI:e06c089566a41c4b5ee160b60fbae8e1e10c0e7b · 27 Sept 2021
Ideal exit: 24 Jun 2022 (T+270) Executives ● Sale0 SEBI
010,000 shares
Equity Shares
SEBI:1511c0d568f366fa2576ec8a989296183f4d31d3 · 27 Sept 2021
Executives ● Purchase0 SEBI
€57,937 9,800 shares @ €5.912
Equity Shares
SEBI:32da8d7c912f1d4d9db504832ae09f596a698347 · 24 Sept 2021
Ideal exit: 21 Jun 2022 (T+270) Executives ● Purchase0 SEBI
€11,572 1,950 shares @ €5.9344
Equity Shares
SEBI:da3603681fcec6d45c53b1c6d36c6d3f53bdf9e4 · 22 Sept 2021
Ideal exit: 19 Jun 2022 (T+270) Executives ● Purchase7 SEBI
€56,385 7,800 shares @ €7.2288 0.0000% mcap 42.4% of flow
Equity Shares
SEBI:fe9844636b32f99c393cfd6c43b8d98c8ab54355 · 23 Jun 2021
Ideal exit: 20 Mar 2022 (T+270) Executives ● Purchase5 SEBI
€20,235 2,800 shares @ €7.2267 0.0000% mcap 15.2% of flow
Equity Shares
SEBI:8de2ea524f0611f5960938f5b20074c58d0281b6 · 22 Jun 2021
Ideal exit: 19 Mar 2022 (T+270) Executives ● Purchase7 SEBI
€56,334 7,870 shares @ €7.1581 0.0000% mcap 42.4% of flow
Equity Shares
SEBI:cbe4bc773724e8e0f53f03e1d6508c57011868b5 · 9 Jun 2021
Ideal exit: 6 Mar 2022 (T+270)